[
    {
        "dbId": 54814,
        "displayName": "UniProt:P11362-1 FGFR1",
        "databaseName": "UniProt",
        "identifier": "P11362",
        "name": [
            "FGFR1"
        ],
        "otherIdentifier": [
            "0003360142",
            "0005220121",
            "11716548_x_at",
            "11727300_a_at",
            "11727301_a_at",
            "11734765_a_at",
            "11747416_a_at",
            "11747417_x_at",
            "2056_at",
            "2057_g_at",
            "207937_x_at",
            "211535_s_at",
            "2260",
            "226705_at",
            "3132013",
            "3132015",
            "3132017",
            "3132018",
            "3132019",
            "3132020",
            "3132021",
            "3132022",
            "3132023",
            "3132025",
            "3132026",
            "3132027",
            "3132028",
            "3132029",
            "3132031",
            "3132033",
            "3132036",
            "3132039",
            "3132041",
            "3132044",
            "3132046",
            "3132055",
            "3132056",
            "3132070",
            "3132072",
            "3132076",
            "3132078",
            "3132080",
            "3132081",
            "3132083",
            "3132095",
            "3132108",
            "3132109",
            "3132111",
            "3132112",
            "3132113",
            "3132114",
            "3132115",
            "3132116",
            "3493097",
            "36168_at",
            "424_s_at",
            "53212_at",
            "8150318",
            "91005_at",
            "A_23_P301304",
            "A_23_P372923",
            "A_24_P4171",
            "GE59934",
            "GO:0000165",
            "GO:0000166",
            "GO:0001501",
            "GO:0001764",
            "GO:0001837",
            "GO:0003674",
            "GO:0004672",
            "GO:0004713",
            "GO:0004714",
            "GO:0005007",
            "GO:0005515",
            "GO:0005524",
            "GO:0005575",
            "GO:0005576",
            "GO:0005622",
            "GO:0005634",
            "GO:0005737",
            "GO:0005829",
            "GO:0005886",
            "GO:0005887",
            "GO:0006464",
            "GO:0006468",
            "GO:0007165",
            "GO:0007169",
            "GO:0007275",
            "GO:0008150",
            "GO:0008201",
            "GO:0008219",
            "GO:0008283",
            "GO:0008284",
            "GO:0008543",
            "GO:0009790",
            "GO:0010518",
            "GO:0010863",
            "GO:0014068",
            "GO:0016020",
            "GO:0016021",
            "GO:0016301",
            "GO:0016310",
            "GO:0016477",
            "GO:0016740",
            "GO:0017134",
            "GO:0018108",
            "GO:0030154",
            "GO:0031410",
            "GO:0032991",
            "GO:0033674",
            "GO:0040011",
            "GO:0042802",
            "GO:0042803",
            "GO:0043009",
            "GO:0043167",
            "GO:0043226",
            "GO:0043235",
            "GO:0043406",
            "GO:0043410",
            "GO:0043536",
            "GO:0045595",
            "GO:0045597",
            "GO:0045666",
            "GO:0046777",
            "GO:0048015",
            "GO:0048705",
            "GO:0048856",
            "GO:0048870",
            "GO:0051897",
            "GO:0090722",
            "GO:1905564",
            "GO:2000546",
            "GO:2001239",
            "HMNXSV003006005",
            "HMNXSV003036243",
            "Hs.748.8.A1_3p_at",
            "ILMN_1729369",
            "ILMN_1796229",
            "ILMN_2398261",
            "PH_hs_0000085",
            "X66945_at",
            "g13186246_3p_a_at",
            "g182560_3p_a_at"
        ],
        "url": "http://purl.uniprot.org/uniprot/P11362-1",
        "checksum": "93A01B5D78C3E72C",
        "comment": [
            "FUNCTION Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.ACTIVITY REGULATION Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by sequential autophosphorylation on tyrosine residues. Inhibited by ARQ 069; this compound maintains the kinase in an inactive conformation and inhibits autophosphorylation. Inhibited by PD173074.SUBUNIT Monomer. Homodimer after ligand binding. Interacts predominantly with FGF1 and FGF2, but can also interact with FGF3, FGF4, FGF5, FGF6, FGF8, FGF10, FGF19, FGF21, FGF22 and FGF23 (in vitro) (PubMed:1697263, PubMed:1722683, PubMed:8663044, PubMed:9655399, PubMed:12181353, PubMed:16597617, PubMed:17623664). Ligand specificity is determined by tissue-specific expression of isoforms, and differences in the third Ig-like domain are crucial for ligand specificity. Affinity for fibroblast growth factors (FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases the affinity for FGF19, FGF21 and FGF23 (PubMed:19966287). Interacts (phosphorylated on Tyr-766) with PLCG1 (via SH2 domains) (PubMed:1656221, PubMed:1379697, PubMed:21765395). Interacts with FRS2 (PubMed:21765395). Interacts with RPS6KA1 (PubMed:15117958). Interacts (via C-terminus) with NEDD4 (via WW3 domain) (PubMed:21765395). Interacts with KL (By similarity). Interacts with SHB (via SH2 domain) (PubMed:12181353). Interacts with GRB10 (PubMed:10454568). Interacts with ANOS1; this interaction does not interfere with FGF2-binding to FGFR1, but prevents binding of heparin-bound FGF2 (PubMed:19696444). Interacts with SOX2 and SOX3. Interacts with FLRT1, FLRT2 and FLRT3 (By similarity). Found in a ternary complex with FGF1 and ITGAV:ITGB3 (PubMed:20422052, PubMed:18441324).TISSUE SPECIFICITY Detected in astrocytoma, neuroblastoma and adrenal cortex cell lines. Some isoforms are detected in foreskin fibroblast cell lines, however isoform 17, isoform 18 and isoform 19 are not detected in these cells.DOMAIN The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans. Isoforms lacking the first Ig-like domain have higher affinity for fibroblast growth factors (FGF) and heparan sulfate proteoglycans than isoforms with all three Ig-like domains.PTM Autophosphorylated. Binding of FGF family members together with heparan sulfate proteoglycan or heparin promotes receptor dimerization and autophosphorylation on tyrosine residues. Autophosphorylation occurs in trans between the two FGFR molecules present in the dimer and proceeds in a highly ordered manner. Initial autophosphorylation at Tyr-653 increases the kinase activity by a factor of 50 to 100. After this, Tyr-583 becomes phosphorylated, followed by phosphorylation of Tyr-463, Tyr-766, Tyr-583 and Tyr-585. In a third stage, Tyr-654 is autophosphorylated, resulting in a further tenfold increase of kinase activity. Phosphotyrosine residues provide docking sites for interacting proteins and so are crucial for FGFR1 function and its regulation.PTM Ubiquitinated. FGFR1 is rapidly ubiquitinated by NEDD4 after autophosphorylation, leading to internalization and lysosomal degradation. CBL is recruited to activated FGFR1 via FRS2 and GRB2, and mediates ubiquitination and subsequent degradation of FGFR1.PTM N-glycosylated in the endoplasmic reticulum. The N-glycan chains undergo further maturation to an Endo H-resistant form in the Golgi apparatus.DISEASE Chromosomal aberrations involving FGFR1 are a cause of chromosome 8p11 myeloproliferative syndrome. Translocation t(8;13)(p11;q12) with ZMYM2. Translocation t(6;8)(q27;p11) with CEP43. Insertion ins(12;8)(p11;p11p22) with FGFR1OP2. Translocation t(8;9)(p12;q33) with CNTRL. Translocation t(2;8)(q12;p11) with RANBP2. Chromosome 8p11 myeloproliferative syndrome is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion proteins FGFR1OP2-FGFR1, CEP43-FGFR1 or FGFR1-CEP43 may exhibit constitutive kinase activity and be responsible for the transforming activity. The fusion protein CNTRL-FGFR1 is found in the cytoplasm, exhibits constitutive kinase activity and may be responsible for the transforming activity.SIMILARITY Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily."
        ],
        "description": [
            "recommendedName: Fibroblast growth factor receptor 1 shortName:FGFR-1 ecNumber evidence=\"15 19 44 45 47 51 67\"2.7.10.1/ecNumber  alternativeName: Basic fibroblast growth factor receptor 1 shortName:BFGFR shortName:bFGF-R-1  alternativeName: Fms-like tyrosine kinase 2 shortName:FLT-2  alternativeName: N-sam  alternativeName: Proto-oncogene c-Fgr  cdAntigenNameCD331/cdAntigenName"
        ],
        "geneName": [
            "FGFR1",
            "BFGFR",
            "CEK",
            "FGFBR",
            "FLG",
            "FLT2",
            "HBGFR"
        ],
        "isSequenceChanged": false,
        "keyword": [
            "3D-structure",
            "Alternative splicing",
            "ATP-binding",
            "Cell membrane",
            "Chromosomal rearrangement",
            "Craniosynostosis",
            "Cytoplasm",
            "Cytoplasmic vesicle",
            "Direct protein sequencing",
            "Disease variant",
            "Disulfide bond",
            "Dwarfism",
            "Glycoprotein",
            "Heparin-binding",
            "Holoprosencephaly",
            "Hypogonadotropic hypogonadism",
            "Immunoglobulin domain",
            "Kallmann syndrome",
            "Kinase",
            "Membrane",
            "Mental retardation",
            "Nucleotide-binding",
            "Nucleus",
            "Phosphoprotein",
            "Receptor",
            "Reference proteome",
            "Repeat",
            "Signal",
            "Transcription",
            "Transcription regulation",
            "Transferase",
            "Transmembrane",
            "Transmembrane helix",
            "Tyrosine-protein kinase",
            "Ubl conjugation"
        ],
        "secondaryIdentifier": [
            "FGFR1_HUMAN",
            "A8K6T9",
            "A8K8V5",
            "C1KBH8",
            "P17049",
            "Q02063",
            "Q02065",
            "Q14306",
            "Q14307",
            "Q53H63",
            "Q59H40",
            "Q5BJG2",
            "Q8N685",
            "Q9UD50",
            "Q9UDF0",
            "Q9UDF1",
            "Q9UDF2"
        ],
        "sequenceLength": 822,
        "chain": [
            "signal peptide:1-21",
            "chain:22-822"
        ],
        "variantIdentifier": "P11362-1",
        "schemaClass": "ReferenceIsoform",
        "className": "ReferenceIsoform"
    },
    {
        "dbId": 8869364,
        "displayName": "ATP(4-) [ChEBI:30616]",
        "databaseName": "ChEBI",
        "identifier": "30616",
        "name": [
            "ATP(4-)",
            "ATP",
            "atp",
            "Adenosine 5'-triphosphate"
        ],
        "url": "http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:30616",
        "formula": "C10H12N5O13P3",
        "schemaClass": "ReferenceMolecule",
        "className": "ReferenceMolecule"
    },
    {
        "dbId": 8869367,
        "displayName": "ADP(3-) [ChEBI:456216]",
        "databaseName": "ChEBI",
        "identifier": "456216",
        "name": [
            "ADP(3-)",
            "ADP",
            "5&apos;-O-[(phosphonatooxy)phosphinato]adenosine",
            "ADP trianion"
        ],
        "url": "http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:456216",
        "formula": "C10H12N5O10P2",
        "schemaClass": "ReferenceMolecule",
        "className": "ReferenceMolecule"
    },
    {
        "dbId": 5654216,
        "displayName": "UniProt:P11362-19 FGFR1",
        "databaseName": "UniProt",
        "identifier": "P11362",
        "name": [
            "FGFR1"
        ],
        "otherIdentifier": [
            "0003360142",
            "0005220121",
            "11716548_x_at",
            "11727300_a_at",
            "11727301_a_at",
            "11734765_a_at",
            "11747416_a_at",
            "11747417_x_at",
            "2056_at",
            "2057_g_at",
            "207937_x_at",
            "211535_s_at",
            "2260",
            "226705_at",
            "3132013",
            "3132015",
            "3132017",
            "3132018",
            "3132019",
            "3132020",
            "3132021",
            "3132022",
            "3132023",
            "3132025",
            "3132026",
            "3132027",
            "3132028",
            "3132029",
            "3132031",
            "3132033",
            "3132036",
            "3132039",
            "3132041",
            "3132044",
            "3132046",
            "3132055",
            "3132056",
            "3132070",
            "3132072",
            "3132076",
            "3132078",
            "3132080",
            "3132081",
            "3132083",
            "3132095",
            "3132108",
            "3132109",
            "3132111",
            "3132112",
            "3132113",
            "3132114",
            "3132115",
            "3132116",
            "3493097",
            "36168_at",
            "424_s_at",
            "53212_at",
            "8150318",
            "91005_at",
            "A_23_P301304",
            "A_23_P372923",
            "A_24_P4171",
            "GE59934",
            "GO:0000165",
            "GO:0000166",
            "GO:0001501",
            "GO:0001764",
            "GO:0001837",
            "GO:0003674",
            "GO:0004672",
            "GO:0004713",
            "GO:0004714",
            "GO:0005007",
            "GO:0005515",
            "GO:0005524",
            "GO:0005575",
            "GO:0005576",
            "GO:0005622",
            "GO:0005634",
            "GO:0005737",
            "GO:0005829",
            "GO:0005886",
            "GO:0005887",
            "GO:0006464",
            "GO:0006468",
            "GO:0007165",
            "GO:0007169",
            "GO:0007275",
            "GO:0008150",
            "GO:0008201",
            "GO:0008219",
            "GO:0008283",
            "GO:0008284",
            "GO:0008543",
            "GO:0009790",
            "GO:0010518",
            "GO:0010863",
            "GO:0014068",
            "GO:0016020",
            "GO:0016021",
            "GO:0016301",
            "GO:0016310",
            "GO:0016477",
            "GO:0016740",
            "GO:0017134",
            "GO:0018108",
            "GO:0030154",
            "GO:0031410",
            "GO:0032991",
            "GO:0033674",
            "GO:0040011",
            "GO:0042802",
            "GO:0042803",
            "GO:0043009",
            "GO:0043167",
            "GO:0043226",
            "GO:0043235",
            "GO:0043406",
            "GO:0043410",
            "GO:0043536",
            "GO:0045595",
            "GO:0045597",
            "GO:0045666",
            "GO:0046777",
            "GO:0048015",
            "GO:0048705",
            "GO:0048856",
            "GO:0048870",
            "GO:0051897",
            "GO:0090722",
            "GO:1905564",
            "GO:2000546",
            "GO:2001239",
            "HMNXSV003006005",
            "HMNXSV003036243",
            "Hs.748.8.A1_3p_at",
            "ILMN_1729369",
            "ILMN_1796229",
            "ILMN_2398261",
            "PH_hs_0000085",
            "X66945_at",
            "g13186246_3p_a_at",
            "g182560_3p_a_at"
        ],
        "url": "http://purl.uniprot.org/uniprot/P11362-19",
        "checksum": "93A01B5D78C3E72C",
        "comment": [
            "FUNCTION Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.ACTIVITY REGULATION Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by sequential autophosphorylation on tyrosine residues. Inhibited by ARQ 069; this compound maintains the kinase in an inactive conformation and inhibits autophosphorylation. Inhibited by PD173074.SUBUNIT Monomer. Homodimer after ligand binding. Interacts predominantly with FGF1 and FGF2, but can also interact with FGF3, FGF4, FGF5, FGF6, FGF8, FGF10, FGF19, FGF21, FGF22 and FGF23 (in vitro) (PubMed:1697263, PubMed:1722683, PubMed:8663044, PubMed:9655399, PubMed:12181353, PubMed:16597617, PubMed:17623664). Ligand specificity is determined by tissue-specific expression of isoforms, and differences in the third Ig-like domain are crucial for ligand specificity. Affinity for fibroblast growth factors (FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases the affinity for FGF19, FGF21 and FGF23 (PubMed:19966287). Interacts (phosphorylated on Tyr-766) with PLCG1 (via SH2 domains) (PubMed:1656221, PubMed:1379697, PubMed:21765395). Interacts with FRS2 (PubMed:21765395). Interacts with RPS6KA1 (PubMed:15117958). Interacts (via C-terminus) with NEDD4 (via WW3 domain) (PubMed:21765395). Interacts with KL (By similarity). Interacts with SHB (via SH2 domain) (PubMed:12181353). Interacts with GRB10 (PubMed:10454568). Interacts with ANOS1; this interaction does not interfere with FGF2-binding to FGFR1, but prevents binding of heparin-bound FGF2 (PubMed:19696444). Interacts with SOX2 and SOX3. Interacts with FLRT1, FLRT2 and FLRT3 (By similarity). Found in a ternary complex with FGF1 and ITGAV:ITGB3 (PubMed:20422052, PubMed:18441324).TISSUE SPECIFICITY Detected in astrocytoma, neuroblastoma and adrenal cortex cell lines. Some isoforms are detected in foreskin fibroblast cell lines, however isoform 17, isoform 18 and isoform 19 are not detected in these cells.DOMAIN The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans. Isoforms lacking the first Ig-like domain have higher affinity for fibroblast growth factors (FGF) and heparan sulfate proteoglycans than isoforms with all three Ig-like domains.PTM Autophosphorylated. Binding of FGF family members together with heparan sulfate proteoglycan or heparin promotes receptor dimerization and autophosphorylation on tyrosine residues. Autophosphorylation occurs in trans between the two FGFR molecules present in the dimer and proceeds in a highly ordered manner. Initial autophosphorylation at Tyr-653 increases the kinase activity by a factor of 50 to 100. After this, Tyr-583 becomes phosphorylated, followed by phosphorylation of Tyr-463, Tyr-766, Tyr-583 and Tyr-585. In a third stage, Tyr-654 is autophosphorylated, resulting in a further tenfold increase of kinase activity. Phosphotyrosine residues provide docking sites for interacting proteins and so are crucial for FGFR1 function and its regulation.PTM Ubiquitinated. FGFR1 is rapidly ubiquitinated by NEDD4 after autophosphorylation, leading to internalization and lysosomal degradation. CBL is recruited to activated FGFR1 via FRS2 and GRB2, and mediates ubiquitination and subsequent degradation of FGFR1.PTM N-glycosylated in the endoplasmic reticulum. The N-glycan chains undergo further maturation to an Endo H-resistant form in the Golgi apparatus.DISEASE Chromosomal aberrations involving FGFR1 are a cause of chromosome 8p11 myeloproliferative syndrome. Translocation t(8;13)(p11;q12) with ZMYM2. Translocation t(6;8)(q27;p11) with CEP43. Insertion ins(12;8)(p11;p11p22) with FGFR1OP2. Translocation t(8;9)(p12;q33) with CNTRL. Translocation t(2;8)(q12;p11) with RANBP2. Chromosome 8p11 myeloproliferative syndrome is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion proteins FGFR1OP2-FGFR1, CEP43-FGFR1 or FGFR1-CEP43 may exhibit constitutive kinase activity and be responsible for the transforming activity. The fusion protein CNTRL-FGFR1 is found in the cytoplasm, exhibits constitutive kinase activity and may be responsible for the transforming activity.SIMILARITY Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily."
        ],
        "description": [
            "recommendedName: Fibroblast growth factor receptor 1 shortName:FGFR-1 ecNumber evidence=\"15 19 44 45 47 51 67\"2.7.10.1/ecNumber  alternativeName: Basic fibroblast growth factor receptor 1 shortName:BFGFR shortName:bFGF-R-1  alternativeName: Fms-like tyrosine kinase 2 shortName:FLT-2  alternativeName: N-sam  alternativeName: Proto-oncogene c-Fgr  cdAntigenNameCD331/cdAntigenName"
        ],
        "geneName": [
            "FGFR1",
            "BFGFR",
            "CEK",
            "FGFBR",
            "FLG",
            "FLT2",
            "HBGFR"
        ],
        "isSequenceChanged": false,
        "keyword": [
            "3D-structure",
            "Alternative splicing",
            "ATP-binding",
            "Cell membrane",
            "Chromosomal rearrangement",
            "Craniosynostosis",
            "Cytoplasm",
            "Cytoplasmic vesicle",
            "Direct protein sequencing",
            "Disease variant",
            "Disulfide bond",
            "Dwarfism",
            "Glycoprotein",
            "Heparin-binding",
            "Holoprosencephaly",
            "Hypogonadotropic hypogonadism",
            "Immunoglobulin domain",
            "Kallmann syndrome",
            "Kinase",
            "Membrane",
            "Mental retardation",
            "Nucleotide-binding",
            "Nucleus",
            "Phosphoprotein",
            "Receptor",
            "Reference proteome",
            "Repeat",
            "Signal",
            "Transcription",
            "Transcription regulation",
            "Transferase",
            "Transmembrane",
            "Transmembrane helix",
            "Tyrosine-protein kinase",
            "Ubl conjugation"
        ],
        "secondaryIdentifier": [
            "FGFR1_HUMAN",
            "A8K6T9",
            "A8K8V5",
            "C1KBH8",
            "P17049",
            "Q02063",
            "Q02065",
            "Q14306",
            "Q14307",
            "Q53H63",
            "Q59H40",
            "Q5BJG2",
            "Q8N685",
            "Q9UD50",
            "Q9UDF0",
            "Q9UDF1",
            "Q9UDF2"
        ],
        "sequenceLength": 822,
        "chain": [
            "signal peptide:1-21",
            "chain:22-822"
        ],
        "variantIdentifier": "P11362-19",
        "schemaClass": "ReferenceIsoform",
        "className": "ReferenceIsoform"
    },
    {
        "dbId": 9603952,
        "displayName": "BGJ-398 [Guide to Pharmacology:7877]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "7877",
        "name": [
            "BGJ-398",
            "BGJ398",
            "BGJ 398",
            "NVP-BGJ398"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7877",
        "approved": false,
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603945,
        "displayName": "lucitanib [Guide to Pharmacology:7649]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "7649",
        "name": [
            "lucitanib",
            "E3810",
            "E-3810 amine"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7649",
        "approved": false,
        "inn": "lucitanib",
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603943,
        "displayName": "brivanib alaninate [Guide to Pharmacology:8097]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "8097",
        "name": [
            "brivanib alaninate",
            "BMS582664",
            "BMS-582664"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8097",
        "approved": false,
        "inn": "brivanib alaninate",
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603941,
        "displayName": "dovitinib [Guide to Pharmacology:5962]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "5962",
        "name": [
            "dovitinib",
            "Chir 258",
            "CHIR-258",
            "TKI 258",
            "TKI-258"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5962",
        "approved": false,
        "inn": "dovitinib",
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603939,
        "displayName": "brivanib [Guide to Pharmacology:5671]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "5671",
        "name": [
            "brivanib",
            "BMS 540215",
            "BMS-540215"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5671",
        "approved": false,
        "inn": "brivanib alaninate",
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603953,
        "displayName": "PD173074 [Guide to Pharmacology:5037]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "5037",
        "name": [
            "PD173074",
            "PD 173074",
            "PD-173074"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5037",
        "approved": false,
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603954,
        "displayName": "AZD4547 [Guide to Pharmacology:7707]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "7707",
        "name": [
            "AZD4547",
            "AZD-4547",
            "KB-74810"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7707",
        "approved": false,
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9608253,
        "displayName": "SU5402 [PubChem Compound:5289418]",
        "databaseName": "PubChem Compound",
        "identifier": "5289418",
        "name": [
            "SU5402"
        ],
        "url": "http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5289418",
        "approved": false,
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    },
    {
        "dbId": 9603950,
        "displayName": "cediranib [Guide to Pharmacology:5664]",
        "databaseName": "Guide to Pharmacology",
        "identifier": "5664",
        "name": [
            "cediranib",
            "AZD2171",
            "AZD 2171",
            "ZD 2171"
        ],
        "url": "https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5664",
        "approved": false,
        "inn": "cediranib",
        "type": "Synthetic organic",
        "schemaClass": "ReferenceTherapeutic",
        "className": "ReferenceTherapeutic"
    }
]
